Behavioral Health Group
Opioid Treatment - Non-Residential
Valhalla Place - Minneapolis
3329 University Ave SE, Minneapolis, MN, 55414
Distance: 1529 Miles
Opioid Use Disorder is an addiction to substances such as heroin, oxycodone or morphine. Detoxification and recovery methods can vary, but often involve stabilization via prescription medication, counseling, and/or behavioral therapy.
There are a large number of regulatory requirements governing Opioid Treatment Programs in Minnesota. It is a program licensed under Minnesota Statute Chapter 245G and/or registered with The Division of Pharmacologic Therapies portion of Substance Abuse and Mental Health Services Administration (SAMHSA). They are also accredited by one of the approved national accreditation bodies and registered with the Drug Enforcement Administration (DEA) as a narcotic treatment program.
Treatment provided as a non-residential outpatient program
The person is currently addicted to an opioid drug and became addicted at least one year before admission for treatment.
Other Services or resources
This provider does not offer other services or resources at this location.
Taxonomy Terms Used: Clicking a taxonomy term from the list below launches a new search.
RX-1700.1700-500Opioid Detoxification Definition
Programs that specialize in providing detoxification services for people who have a physical dependency on an opioid substance (usually heroin, oxycodone or morphine). Detoxification methods vary but often entail stabilization via prescription medication such as methadone, buprenorphine (Subutex), buprenorphine-naloxone (Suboxone) or naltrexone administered by medical professionals. Specialized opioid detoxification programs can be either inpatient or outpatient.
RX-8450.5000Medication Assisted Maintenance Treatment for Substance Use Disorders Definition
Programs that provide treatment which includes approved medication (e.g., methadone, buprenorphine, naltrexone, antabuse) to support the efforts of individuals with an opioid or alcohol use disorder to abstain from or reduce their use of opioids (usually heroin or painkillers such as oxycontin or morphine) or alcohol. The extended-release, injectable form of naltrexone (Vivitrol) may also be used. The objective of maintenance is to gradually reduce the amount of the substitute drug that is required in order to reduce and, if possible, eventually eliminate dependency altogether. Medication assisted maintenance treatment (MAT) may be provided in an outpatient treatment program (OTP) or OTP unit such as a pharmacy or physician's office, or for buprenorphine products (Bunavail, Suboxone, Subutex, Zubslov), a physician's office or other health care setting. Methadone maintenance treatment is provided in a clinic. It is recommended that medication assisted maintenance treatment be provided in combination with counseling and behavioral therapies.
YF-8000.1800-620Opioid Use Disorder Definition
A disorder that is characterized by the use of opiates including heroin, opium, nonprescription methadone and morphine that are valued for the physical and psychological symptoms they produce including insensitivity to physical or emotional pain, euphoria, drowsiness and sleep. Negative side effects include the risk of an overdose which may result in death through respiratory depression; severe withdrawal symptoms if the drug is withheld; and associated health problems including the risk of hepatitis, blood poisoning, abscesses of the liver, brain and lungs and AIDS.